Evidence map›Paper›PMID 34683991›Full record

ArticlePharmaceutics2021

Molecular Epidemiology, Antimicrobial Surveillance, and PK/PD Analysis to Guide the Treatment of

Rodrigo Alonso, Ainara Rodríguez-Achaerandio, Amaia Aguirre-Quiñonero, Aitor Artetxe, Ilargi Martínez-Ballesteros, Alicia Rodríguez-Gascón, Javier Garaizar, Andrés Canut

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Molecular epidemiology and pharmacokinetic-pharmacodynamic analysis of Neisseria gonorrhoeae strains in Northern Spain.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. The Optimal Management ofMicroorganisms · 2022
    Review
  7. [The postal code as a "bar code" of antimicrobial resistance].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2022
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Rodrigo AlonsoDepartment of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-8129-4850
Ainara Rodríguez-AchaerandioBioaraba Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy Group, 01009 Vitoria-Gasteiz, Spain.
Amaia Aguirre-QuiñoneroBioaraba Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy Group, 01009 Vitoria-Gasteiz, Spain.
Aitor ArtetxeDepartment of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.
Ilargi Martínez-BallesterosDepartment of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-8867-1487
Alicia Rodríguez-GascónBioaraba Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy Group, 01009 Vitoria-Gasteiz, Spain.ORCID 0000-0002-3195-6385
Javier GaraizarDepartment of Immunology, Microbiology and Parasitology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.ORCID 0000-0002-3093-7078
Andrés CanutBioaraba Microbiology, Infectious Disease, Antimicrobial Agents, and Gene Therapy Group, 01009 Vitoria-Gasteiz, Spain.ORCID 0000-0003-3836-9906
University of the Basque Country · ESHospital Universitario Araba · ES

Funding

University of the Basque Country UPV/EHU GIU20/048University of the Basque Country UPV/EHU PA20/03
6 · The paper itself

Abstract

The aim of this study was to apply molecular epidemiology, antimicrobial surveillance, and PK/PD analysis to guide the antimicrobial treatment of gonococci infections in a region of the north of Spain. Antibiotic susceptibility testing was performed on all isolates (2017 to 2019,

Indexed as

antibiotic resistanceazithromycincephalosporinsN. gonorrhoeaepharmacokinetic/pharmacodynamic (PK/PD) analysiswhole-genome sequencing (WGS)

Identifiers

PMID34683991
PMCPMC8541456
OpenAlexW3206935972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.